Air Transportation of the COVID-19 Vaccines, 5932-5933 [2022-02017]

Download as PDF 5932 Federal Register / Vol. 87, No. 22 / Wednesday, February 2, 2022 / Notices level information will be provided to the participating LPCs to allow them to gauge where they stand in terms of their technical capabilities compared to their peers which could help give them useful information that informs their individual priorities and investment plans. Rebecca L. Coffey, Agency Records Officer. [FR Doc. 2022–02125 Filed 2–1–22; 8:45 am] BILLING CODE 8120–08–P DEPARTMENT OF TRANSPORTATION Federal Aviation Administration [Docket No. FAA–2016–6772; Summary Notice No. –2022–03] Petition for Exemption; Summary of Petition Received; Cobalt Air, LLC Federal Aviation Administration (FAA), Department of Transportation (DOT). ACTION: Notice. AGENCY: This notice contains a summary of a petition seeking relief from specified requirements of Federal Aviation Regulations. The purpose of this notice is to improve the public’s awareness of, and participation in, the FAA’s exemption process. Neither publication of this notice nor the inclusion nor omission of information in the summary is intended to affect the legal status of the petition or its final disposition. SUMMARY: Comments on this petition must identify the petition docket number and must be received on or before February 22, 2022. ADDRESSES: Send comments identified by docket number FAA–2016–6772 using any of the following methods: • Federal eRulemaking Portal: Go to https://www.regulations.gov and follow the online instructions for sending your comments electronically. • Mail: Send comments to Docket Operations, M–30; U.S. Department of Transportation, 1200 New Jersey Avenue SE, Room W12–140, West Building Ground Floor, Washington, DC 20590–0001. • Hand Delivery or Courier: Take comments to Docket Operations in Room W12–140 of the West Building Ground Floor at 1200 New Jersey Avenue SE, Washington, DC 20590– 0001, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. • Fax: Fax comments to Docket Operations at (202) 493–2251. jspears on DSK121TN23PROD with NOTICES1 DATES: VerDate Sep<11>2014 21:31 Feb 01, 2022 Jkt 256001 Privacy: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to https://www.regulations.gov, as described in the system of records notice (DOT/ALL–14 FDMS), which can be reviewed at https://www.dot.gov/ privacy. Docket: Background documents or comments received may be read at https://www.regulations.gov at any time. Follow the online instructions for accessing the docket or go to the Docket Operations in Room W12–140 of the West Building Ground Floor at 1200 New Jersey Avenue SE, Washington, DC 20590–0001, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. FOR FURTHER INFORMATION CONTACT: Sean O’Tormey at 202–267–4044, Office of Rulemaking, Federal Aviation Administration, 800 Independence Avenue SW, Washington, DC 20591. Timothy R. Adams, Deputy Executive Director, Office of Rulemaking. Petition for Exemption Docket No.: FAA–2016–6772. Petitioner: Cobalt Air, LLC. Section(s) of 14 CFR Affected: § 135.419(a). Description of Relief Sought: Petitioner Cobalt Air, LLC seeks an exemption from the exclusive use requirement referenced in § 135.419(a). Because the FAA has not previously granted exemptions from the exclusive use requirement referenced in § 135.419(a), the FAA seeks comments on the request for relief from § 135.419(a) for the Pilatus PC–12 aircraft. See Petitioner’s First Amended Request for Exemption and Request for Consolidation with Pending Request for Reconsideration of Denial (June 4, 2019), available at https:// www.regulations.gov/document/FAA2016-6772-0004. [FR Doc. 2022–02116 Filed 2–1–22; 8:45 am] BILLING CODE 4910–13–P DEPARTMENT OF TRANSPORTATION Federal Aviation Administration [Docket No. FAA–2022–0116] Air Transportation of the COVID–19 Vaccines Federal Aviation Administration (FAA), DOT. AGENCY: PO 00000 Frm 00154 Fmt 4703 Sfmt 4703 Notice and request for comments. ACTION: In accordance with the Paperwork Reduction Act of 1995, the FAA invites public comments about its intention to request the Office of Management and Budget (OMB) grant emergency approval for a new information collection. The Federal Register Notice with a 60-day comment period soliciting comments is waived, as this is an emergency action in response to the COVID–19 public health emergency. This action would enable the FAA to collect voluntary information from air carriers authorized to conduct operations under the Code of Federal Regulations that participate or have participated in transport of the COVID–19 vaccines to support continued operational safety and efficiency. SUMMARY: Written comments should be submitted by March 4, 2022. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Ben Supko, Executive Director, FAA Office of Hazardous Materials Safety (AXH–1), by email at: hazmatinfo@faa.gov; phone: (202) 267–7211. SUPPLEMENTARY INFORMATION: Public Comments Invited: You are asked to comment on any aspect of this information collection, including (a) whether the proposed collection of information is necessary for the FAA’s performance; (b) the accuracy of the estimated burden; (c) ways for the FAA to enhance the quality, utility and clarity of the information collection; and (d) ways that the burden could be minimized without reducing the quality of the collected information. OMB Control Number: To be determined. Title: Air Transportation of the COVID–19 Vaccines. Form Numbers: N/A. Type of Review: Clearance of a new information collection. Background: The Federal Register Notice with a 60-day comment period soliciting comments on the following collection of information is waived, as this is an emergency action regarding transport of the COVID–19 vaccines. The FAA seeks this information collection in connection with the FAA DATES: E:\FR\FM\02FEN1.SGM 02FEN1 jspears on DSK121TN23PROD with NOTICES1 Federal Register / Vol. 87, No. 22 / Wednesday, February 2, 2022 / Notices COVID–19 Vaccine Air Transport Team’s work with air carriers, and other aviation stakeholders to aid in the safe, expeditious, and efficient transport of the COVID–19 vaccines. This new collection would enable the FAA to collect voluntary information from air carriers authorized to operate under parts 121 and 135 of title 14, Code of Federal Regulations (14 CFR) that participate or have participated in transport of the COVID–19 vaccines. The continuing mission of the FAA is to provide the safest, most efficient aerospace system in the world. The FAA’s authority on aviation safety is found in title 49, United States Code (U.S.C.). The authority described in 49 U.S.C. 106(f) vests final authority in the Administrator to carry out all functions, powers, and duties of the Administration relating to the promulgation of regulations, rules, orders, circulars, bulletins, and other official publications of the Administration. Section 44701(a)(5) of title 49, U.S.C. also requires the Administrator to promulgate regulations and minimum standards for other practices, methods, and procedures the Administrator finds necessary for safety in air commerce and national security. Pursuant to 49 U.S.C. 44701(b)(1), the Administrator may prescribe minimum safety standards for an air carrier to whom an air carrier operating certificate is issued under 49 U.S.C. 44705. When prescribing a regulation or minimum standard under section 44701(a) or (b), the Administrator must consider the duty of an air carrier to provide service with the highest possible degree of safety in the public interest, as prescribed by 49 U.S.C. 44701(d). Regulations and minimum standards necessary for the safe and efficient air transport of the COVID–19 vaccines are within the scope of these authorities and are in the public interest. The safe and efficient distribution of COVID–19 vaccines helps save lives, reduce the severity of COVID–19 illnesses and the associated strains on healthcare systems, and facilitate economic recovery. The FAA has worked closely with air carriers, industry associations, and other aviation stakeholders to address safety matters, such as changed packaging configurations, data loggers, and increased dry ice limits in the context of air carrier operations to support transport of the COVID–19 vaccines. For example, on December 10, 2020, the FAA issued ‘‘Safety Alert for Operators VerDate Sep<11>2014 21:31 Feb 01, 2022 Jkt 256001 5933 20017,’’ 1 which identifies specific considerations related to the air transport of dry ice. Since December 4, 2020, the Department of Transportation and the FAA have led a recurrent Vaccine Distribution Engagement Meeting (VDEM) to bring together government and industry to share ideas, successes, challenges, and ask questions related to transporting the COVID–19 vaccines. Aviation industry associations, air carriers, government partners, and other stakeholders have engaged to provide information and voice concerns—with no consensus recommendations sought for any governmental action—related to the logistics of transport by air of the COVID–19 vaccines. The entities represented at the recurrent VDEMs have collaborated to successfully transport the COVID–19 vaccines, while upholding the highest standards of aviation safety. During VDEMs, both FAA and industry stakeholders identified common interest in querying participants to capture lessons learned. Accordingly, the FAA seeks voluntary information from air carriers authorized to operate under 14 CFR parts 121 and 135 that participate or have participated in transport of the COVID–19 vaccines. Information collected from these stakeholders may further enhance safety efforts and facilitate development of pertinent regulations, minimum standards, guidance, and other information. 6. What additional regulations, minimum standards, guidance, or other information would you like to see concerning the air transport of dry ice? Respondents: The FAA estimates that a total of 39 entities will voluntarily submit responses for this information collection request. Frequency: The FAA expects the submissions warrant a one-time burden to take place over the next three to six months for entities that choose to comply. The FAA may conduct this survey additional times, depending upon the duration of the COVID–19 pandemic, any significant developments in COVID–19 vaccine logistics and transport, and interest from VDEM participants. Estimated Average Burden per Response: 5 hours reporting and 0 hours recordkeeping. Estimated Total Annual Burden: 195 hours reporting and 0 hours recordkeeping. Questions 1. Did the volume of vaccines transported per pound of dry ice increase over the duration of the COVID–19 pandemic? Please provide data that captures the change. 2. Were there observed lower sublimation rates due to improved packaging technology or other factors, and to what factors do you attribute these lower sublimation rates? 3. What risk mitigations have you utilized to enable safe and efficient air operations with larger than normal quantities of dry ice? 4. Was there anything that limited your ability to transport COVID–19 vaccines efficiently while maintaining aviation safety? If so, please describe. 5. What are key takeaways or accomplishments from the COVID–19 vaccine transportation effort over the past year that show the value of working closely with shippers, airframe manufacturers, and the FAA for datadriven safe and efficient operations? Proposed Agency Information Collection Activities; Comment Request 1 Available at: https://www.faa.gov/other_visit/ aviation_industry/airline_operators/airline_safety/ safo/all_safos/media/2020/SAFO20017.pdf. PO 00000 Frm 00155 Fmt 4703 Sfmt 4703 Issued in Washington, DC, on January 27, 2022. Daniel Benjamin Supko, Executive Director, FAA, Office of Hazardous Materials Safety. [FR Doc. 2022–02017 Filed 2–1–22; 8:45 am] BILLING CODE 4910–13–P DEPARTMENT OF TRANSPORTATION Federal Railroad Administration [Docket No. FRA–2022–0002–N–2] Federal Railroad Administration (FRA), U.S. Department of Transportation (DOT). ACTION: Notice of information collection; request for comment. AGENCY: Under the Paperwork Reduction Act of 1995 (PRA) and its implementing regulations, FRA seeks approval of the Information Collection Request (ICR) abstracted below. Before submitting this ICR to the Office of Management and Budget (OMB) for approval, FRA is soliciting public comment on specific aspects of the activities identified in the ICR. DATES: Interested persons are invited to submit comments on or before April 4, 2022. ADDRESSES: Written comments and recommendations for the proposed ICR should be submitted on regulations.gov to the docket, Docket No. FRA–2022– 0002. All comments received will be posted without change to the docket, SUMMARY: E:\FR\FM\02FEN1.SGM 02FEN1

Agencies

[Federal Register Volume 87, Number 22 (Wednesday, February 2, 2022)]
[Notices]
[Pages 5932-5933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02017]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Docket No. FAA-2022-0116]


Air Transportation of the COVID-19 Vaccines

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, the 
FAA invites public comments about its intention to request the Office 
of Management and Budget (OMB) grant emergency approval for a new 
information collection. The Federal Register Notice with a 60-day 
comment period soliciting comments is waived, as this is an emergency 
action in response to the COVID-19 public health emergency. This action 
would enable the FAA to collect voluntary information from air carriers 
authorized to conduct operations under the Code of Federal Regulations 
that participate or have participated in transport of the COVID-19 
vaccines to support continued operational safety and efficiency.

DATES: Written comments should be submitted by March 4, 2022.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Ben Supko, Executive Director, FAA 
Office of Hazardous Materials Safety (AXH-1), by email at: 
[email protected]; phone: (202) 267-7211.

SUPPLEMENTARY INFORMATION: 
    Public Comments Invited: You are asked to comment on any aspect of 
this information collection, including (a) whether the proposed 
collection of information is necessary for the FAA's performance; (b) 
the accuracy of the estimated burden; (c) ways for the FAA to enhance 
the quality, utility and clarity of the information collection; and (d) 
ways that the burden could be minimized without reducing the quality of 
the collected information.
    OMB Control Number: To be determined.
    Title: Air Transportation of the COVID-19 Vaccines.
    Form Numbers: N/A.
    Type of Review: Clearance of a new information collection.
    Background: The Federal Register Notice with a 60-day comment 
period soliciting comments on the following collection of information 
is waived, as this is an emergency action regarding transport of the 
COVID-19 vaccines. The FAA seeks this information collection in 
connection with the FAA

[[Page 5933]]

COVID-19 Vaccine Air Transport Team's work with air carriers, and other 
aviation stakeholders to aid in the safe, expeditious, and efficient 
transport of the COVID-19 vaccines. This new collection would enable 
the FAA to collect voluntary information from air carriers authorized 
to operate under parts 121 and 135 of title 14, Code of Federal 
Regulations (14 CFR) that participate or have participated in transport 
of the COVID-19 vaccines.
    The continuing mission of the FAA is to provide the safest, most 
efficient aerospace system in the world. The FAA's authority on 
aviation safety is found in title 49, United States Code (U.S.C.). The 
authority described in 49 U.S.C. 106(f) vests final authority in the 
Administrator to carry out all functions, powers, and duties of the 
Administration relating to the promulgation of regulations, rules, 
orders, circulars, bulletins, and other official publications of the 
Administration. Section 44701(a)(5) of title 49, U.S.C. also requires 
the Administrator to promulgate regulations and minimum standards for 
other practices, methods, and procedures the Administrator finds 
necessary for safety in air commerce and national security. Pursuant to 
49 U.S.C. 44701(b)(1), the Administrator may prescribe minimum safety 
standards for an air carrier to whom an air carrier operating 
certificate is issued under 49 U.S.C. 44705. When prescribing a 
regulation or minimum standard under section 44701(a) or (b), the 
Administrator must consider the duty of an air carrier to provide 
service with the highest possible degree of safety in the public 
interest, as prescribed by 49 U.S.C. 44701(d). Regulations and minimum 
standards necessary for the safe and efficient air transport of the 
COVID-19 vaccines are within the scope of these authorities and are in 
the public interest. The safe and efficient distribution of COVID-19 
vaccines helps save lives, reduce the severity of COVID-19 illnesses 
and the associated strains on healthcare systems, and facilitate 
economic recovery.
    The FAA has worked closely with air carriers, industry 
associations, and other aviation stakeholders to address safety 
matters, such as changed packaging configurations, data loggers, and 
increased dry ice limits in the context of air carrier operations to 
support transport of the COVID-19 vaccines. For example, on December 
10, 2020, the FAA issued ``Safety Alert for Operators 20017,'' \1\ 
which identifies specific considerations related to the air transport 
of dry ice.
---------------------------------------------------------------------------

    \1\ Available at: https://www.faa.gov/other_visit/aviation_industry/airline_operators/airline_safety/safo/all_safos/media/2020/SAFO20017.pdf.
---------------------------------------------------------------------------

    Since December 4, 2020, the Department of Transportation and the 
FAA have led a recurrent Vaccine Distribution Engagement Meeting (VDEM) 
to bring together government and industry to share ideas, successes, 
challenges, and ask questions related to transporting the COVID-19 
vaccines. Aviation industry associations, air carriers, government 
partners, and other stakeholders have engaged to provide information 
and voice concerns--with no consensus recommendations sought for any 
governmental action--related to the logistics of transport by air of 
the COVID-19 vaccines. The entities represented at the recurrent VDEMs 
have collaborated to successfully transport the COVID-19 vaccines, 
while upholding the highest standards of aviation safety.
    During VDEMs, both FAA and industry stakeholders identified common 
interest in querying participants to capture lessons learned. 
Accordingly, the FAA seeks voluntary information from air carriers 
authorized to operate under 14 CFR parts 121 and 135 that participate 
or have participated in transport of the COVID-19 vaccines. Information 
collected from these stakeholders may further enhance safety efforts 
and facilitate development of pertinent regulations, minimum standards, 
guidance, and other information.

Questions

    1. Did the volume of vaccines transported per pound of dry ice 
increase over the duration of the COVID-19 pandemic? Please provide 
data that captures the change.
    2. Were there observed lower sublimation rates due to improved 
packaging technology or other factors, and to what factors do you 
attribute these lower sublimation rates?
    3. What risk mitigations have you utilized to enable safe and 
efficient air operations with larger than normal quantities of dry ice?
    4. Was there anything that limited your ability to transport COVID-
19 vaccines efficiently while maintaining aviation safety? If so, 
please describe.
    5. What are key takeaways or accomplishments from the COVID-19 
vaccine transportation effort over the past year that show the value of 
working closely with shippers, airframe manufacturers, and the FAA for 
data-driven safe and efficient operations?
    6. What additional regulations, minimum standards, guidance, or 
other information would you like to see concerning the air transport of 
dry ice?
    Respondents: The FAA estimates that a total of 39 entities will 
voluntarily submit responses for this information collection request.
    Frequency: The FAA expects the submissions warrant a one-time 
burden to take place over the next three to six months for entities 
that choose to comply. The FAA may conduct this survey additional 
times, depending upon the duration of the COVID-19 pandemic, any 
significant developments in COVID-19 vaccine logistics and transport, 
and interest from VDEM participants.
    Estimated Average Burden per Response: 5 hours reporting and 0 
hours recordkeeping.
    Estimated Total Annual Burden: 195 hours reporting and 0 hours 
recordkeeping.

    Issued in Washington, DC, on January 27, 2022.
Daniel Benjamin Supko,
Executive Director, FAA, Office of Hazardous Materials Safety.
[FR Doc. 2022-02017 Filed 2-1-22; 8:45 am]
BILLING CODE 4910-13-P